Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Creating a database for colon cancer and colic tumors

Official title: Prospective, Multicenter, Clinical and Biological Database Set-up in Colon Cancer and Colic Tumors

Run by Institut du Cancer de Montpellier - Val d'Aurelle · NCT03976960 · Data updated 2026-11-12

This study is trying to build a database of tissue and blood samples from colon cancer patients to help find new ways to understand and treat the disease.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
Academic / other
Locations2 sites (Montpellier, Hérault and 1 other locations)
StatusRecruiting
StartedSeptember 19, 2018
Main results expectedDecember 2025
Study endsDecember 2030
Registry record updatedFebruary 12, 2025
Trial IDNCT03976960 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients undergoing surgery for colon cancer at any stage, as well as those with related metastatic conditions.

Probably not a fit

Patients who are not undergoing surgery for colon cancer or who do not meet the eligibility criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop a clinical and biological database focused on colon cancer and colic tumors to enhance understanding of tumor invasion and metastatic processes. By collecting tissue and blood samples from patients undergoing surgery for various stages of colon cancer, the researchers hope to identify new biomarkers and therapeutic targets. The initiative addresses the current limitations in studying early tumorigenesis and advanced disease stages due to insufficient sample availability.

Why it matters

Potential benefit: If successful, this study could lead to the discovery of new biomarkers and drugs for colon cancer treatment.

How similar studies have gone: Other studies focusing on biological databases in cancer have shown promise in identifying new treatment avenues, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient undergoing colon cancer surgery (stage I, II, III and IV)
2. Patient operated for liver or lung or peritoneal carcinomatosis metastases originating from colon cancer
3. Patient operated for pre-neoplastic lesion (adenomatous polyp /villous adenoma polyp),
4. Patient with familial polyposis eligible for colectomy
5. Age \> 18 years
6. Signed informed consent

Exclusion Criteria:

1. Patient not affiliated to Social Protection system
2. Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
3. Patient under guardianship
4. Minor patient

Where it's running

  • CHRU de Montpellier
    Montpellier, Hérault, France
    Recruiting
  • Institut Régional du cancer de Montpellier
    Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.